Label schedules
Liraglutide dose schedule
Liraglutide, sold as Saxenda, has a daily injection schedule whose escalation phases are described in weeks. That combination can make a quick chart confusing: a weekly phase does not mean a weekly injection. This page focuses on the adult Saxenda schedule and the details needed to read it accurately. It does not extend the table to every liraglutide product or to pediatric prescribing. Saxenda label
Sources checked
The adult label sequence
The first week uses 0.6 mg daily. The next weekly stages are 1.2, 1.8, and 2.4 mg daily, followed by 3 mg daily from week five onward. In adults, the label identifies 3 mg as the maintenance amount and the lower amounts as escalation doses. It describes delaying an increase for approximately one additional week when the increased dose is not tolerated. Saxenda label
The maintenance row has a different meaning from the first four rows. Those earlier rows describe a transition, while the later row describes the adult ongoing amount in this specific label. The chart is not an invitation to select a preferred row. It is a reference for understanding a prescription and for checking that a record says daily where the label says daily.
| Week | Amount each day | Stage |
|---|---|---|
| 1 | 0.6 mg daily | Initiation |
| 2 | 1.2 mg daily | Escalation |
| 3 | 1.8 mg daily | Escalation |
| 4 | 2.4 mg daily | Escalation |
| 5 onward | 3 mg daily | Adult maintenance |
Where this reference stops
The same label contains separate pediatric provisions: escalation may take up to eight weeks, and 2.4 mg can be a maintenance amount for pediatric patients who do not tolerate 3 mg. Those statements do not change the adult maintenance description. Keeping age-specific instructions separate avoids implying that a number found anywhere in the label applies to everyone using the medicine. Saxenda label
The adult section also contains a sixteen-week assessment of body-weight change and instructions for the clinician based on that assessment. A brief escalation chart does not reproduce the full clinical decision process. The linked prescribing information is therefore part of the reference, including sections beyond the table. A calendar alone has no basis to interpret whether a labeled assessment has been met. Saxenda label
The pen amount and a volume calculation are different
Saxenda is supplied as a prefilled pen with liraglutide at 6 mg/mL in a 3 mL container. Its labeled selectable doses include the amounts in the escalation table. That product information is distinct from a general calculation involving a hypothetical vial. A calculator does not provide alternate pen instructions, and an insulin-syringe marking does not become a branded pen setting. Saxenda labelArithmetic
As arithmetic only, a hypothetical 6 mg vial in 2 mL has a concentration of 3 mg/mL. A volume of 0.20 mL contains 0.6 mg; on a U-100 scale, that volume is 20 units. The result follows from those particular inputs and changes if the concentration changes. It gives no instruction to prepare, extract, or administer a product. Arithmetic
A daily log can retain the phase boundaries
PinPoint supports daily reminders and titration phases for step-ups and step-downs. Injection entries can record the compound, dose, site, and pain level. Backfilling makes past dates part of the history, while the calendar provides a view of what was entered over time. This record can distinguish the last entry of one phase from the first entry of another. App features
The app also supports side-effect severity ratings and daily notes, as well as exports in PDF, CSV, and JSON. Those features document observations; they do not determine a medication change. The modeled Home curve is based on published population-average half-life data and does not measure individual levels. It should be read as a visualization of an entered pattern rather than as evidence that a clinical threshold has been reached. App features
Useful distinctions
Questions
Why do the table headings use both weeks and days?
The label changes the amount in weekly stages while describing daily administration. The week identifies the escalation phase, and the daily dose column identifies how the amount is expressed. Saxenda label
Does this chart apply to every liraglutide brand?
This page is deliberately limited to the Saxenda adult label. A shared ingredient name is not sufficient to copy a schedule into a different product or population. Saxenda label
Your record, together
Keep the details attached to the date.
Dose history, reminders, daily notes, and the context you choose to record. PinPoint app features.
Get PinPoint on the App StoreSources & scope
Label facts link to the full prescribing information. Product claims use the supplied PinPoint app description. Numerical examples show their assumptions and arithmetic.
- PinPoint feature description
Only feature claims verified against the supplied description. No prices, clinical recommendations or inferred tablet inventory.
- Arithmetic shown on this page
Numerical derivations, dimensional distinctions and declared assumptions only.
Concentration mg/mL = total mg / final mL. U-100 volume mL = units / 100. Contained mg = concentration * volume. These are hypothetical examples, not preparation instructions or clinical amounts.
- How to read this reference
Editorial organization, explicit scope limits, and interpretation of the cited label or app evidence. No additional medical facts.
- Saxenda prescribing information
2 (schedule/administration), 3 (presentations), 6.1–6.2 (adverse reactions), 14 (study identity), Medication Guide and Instructions for Use. DailyMed set ID:
3946d389-0926-4f77-a708-0acb8153b143.